|
MTRR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.457100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.596000E-03 |
| Normal-vs-Stage2 |
4.719400E-01 |
| Normal-vs-Stage3 |
4.968200E-02 |
| Normal-vs-Stage4 |
5.950200E-01 |
| Stage1-vs-Stage2 |
4.193400E-01 |
| Stage1-vs-Stage3 |
9.553000E-01 |
| Stage1-vs-Stage4 |
1.934390E-01 |
| Stage2-vs-Stage3 |
5.033600E-01 |
| Stage2-vs-Stage4 |
8.076000E-01 |
| Stage3-vs-Stage4 |
2.935600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.844900E-03 |
| Normal-vs-AfricanAmerican |
1.158440E-01 |
| Normal-vs-Asian |
3.304100E-02 |
| Caucasian-vs-AfricanAmerican |
6.415300E-04 |
| Caucasian-vs-Asian |
2.193400E-01 |
| AfricanAmerican-vs-Asian |
2.403100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.153750E-01 |
| Normal-vs-Female |
2.572400E-04 |
| Male-vs-Female |
4.003700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.731520E-02 |
| Normal-vs-Age(41-60Yrs) |
9.320200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.449700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.026000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.883150E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.027590E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.311700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.208040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.826000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.109600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.000000E-01 |
| Normal-vs-Grade 2 |
1.400350E-03 |
| Normal-vs-Grade 3 |
2.729600E-02 |
| Normal-vs-Grade 4 |
7.359400E-01 |
| Grade 1-vs-Grade 2 |
7.059800E-01 |
| Grade 1-vs-Grade 3 |
9.043800E-01 |
| Grade 1-vs-Grade 4 |
4.516000E-01 |
| Grade 2-vs-Grade 3 |
4.910400E-01 |
| Grade 2-vs-Grade 4 |
2.146500E-02 |
| Grade 3-vs-Grade 4 |
9.094000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.5187999968802E-08 |
| Normal-vs-ccB subtype |
6.306400E-01 |
| ccA subtype-vs-ccB subtype |
3.978100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.224400E-03 |
| Normal-vs-N1 |
5.302000E-01 |
| N0-vs-N1 |
8.140600E-01 |
|
|
